Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius SE & Co. KGaA    FRE   DE0005785604

FRESENIUS SE & CO. KGAA

(FRE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

FRESENIUS SE : DZ Bank keeps its Buy rating

11/26/2020 | 09:56am EST

Sven Kürten from DZ Bank retains his positive opinion on the stock with a Buy rating.


© MarketScreener with dpa-AFX Analyser 2020
All news about FRESENIUS SE & CO. KGAA
01/19Cytosorbents' CytoSorb Blood Purification Technology Gets Nod from South Kore..
MT
01/19DGAP-DD : Fresenius SE & Co. KGaA english
DJ
01/18FMC FRESENIUS MEDICAL CARE AG & CO K : Goldman Sachs maintains a Buy rating
MD
01/18FRESENIUS SE : Goldman Sachs maintains a Buy rating
MD
01/13FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Buy rating from JP Morgan
MD
01/12FRESENIUS SE : Buy rating from JP Morgan
MD
01/11FRESENIUS SE : Jefferies remains a Sell rating
MD
01/11FMC FRESENIUS MEDICAL CARE AG & CO K : Downgraded from Neutral to Sell by Jeffer..
MD
01/07European ADRs Move Higher in Thursday Trading
MT
01/07FRESENIUS SE : Bernstein gives a Buy rating
MD
More news
Financials
Sales 2020 36 285 M 44 057 M 44 057 M
Net income 2020 1 792 M 2 175 M 2 175 M
Net Debt 2020 24 048 M 29 200 M 29 200 M
P/E ratio 2020 12,1x
Yield 2020 2,06%
Capitalization 21 591 M 26 171 M 26 216 M
EV / Sales 2020 1,26x
EV / Sales 2021 1,14x
Nbr of Employees 309 114
Free-Float 72,0%
Chart FRESENIUS SE & CO. KGAA
Duration : Period :
Fresenius SE & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS SE & CO. KGAA
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 48,44 €
Last Close Price 38,73 €
Spread / Highest target 75,6%
Spread / Average Target 25,1%
Spread / Lowest Target -54,4%
EPS Revisions
Managers and Directors
NameTitle
Stephan Sturm President & Chief Executive Officer
Gerd Krick Chairman-Supervisory Board
Rachel Clare Empey Chief Financial Officer
Niko Stumpfögger Deputy Chairman-Supervisory Board
Klaus-Peter Müller Member-Supervisory Board